These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. Wattmo C, Wallin AK, Londos E, Minthon L. Gerontologist; 2011 Feb; 51(1):17-27. PubMed ID: 20562471 [Abstract] [Full Text] [Related]
6. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome. Hemingway-Eltomey JM, Lerner AJ. Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967 [No Abstract] [Full Text] [Related]
8. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211 [Abstract] [Full Text] [Related]
10. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G, Hyvärinen M, Josiassen MK, Kørner A, Lehto H, Wetterberg P. Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
16. How do we treat people with dementia in Croatia. Mimica N, Presecki P. Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784 [Abstract] [Full Text] [Related]